Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Korro Bio
Biotech
Korro lays off 20% to fund genetic med trials, Novo collab
Korro is laying off a fifth of its workforce as the Novo-partnered biotech funnels resources to its candidate for a genetic lung and liver disease.
James Waldron
May 8, 2025 10:00am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
Novo Nordisk signs $530M biobucks deal to sing in Korro's opera
Sep 16, 2024 9:40am
Korro Bio merges with off-pitch Frequency, tacks on $117M
Jul 14, 2023 9:50am
Billy Dunn departs FDA—Chutes & Ladders
Mar 3, 2023 9:30am
Korro Bio rings in new year with $116M for OPERA RNA editing
Jan 5, 2022 7:30am
